Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simo decoction oral liquid for postprandial distress syndrome
ChiCTR2100053738Phase 4Completed
- Sponsor
- Xiyuan Hospital
- Start
- Sep 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of simotang in functional dyspepsia (FD) (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Symptoms improvement rate. Started Sep 2021; status: completed.
02
Drugs
simotang
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2100053738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053738.